Yosemite will fund companies through both grants and venture investing. The fund will target early-stage companies in therapeutics, diagnostics and digital health, according to an Aug. 1 Yosemite news release provided to Becker’s.
Yosemite is partnering with hospitals, endowments and global family offices.
“We’re on a mission to lead the next chapter in the fight against cancer and forming our own standalone entity provides us the flexibility to best propel great ideas until they’re at scale,” Mr. Jobs said. “We believe this first close demonstrates investor confidence in Yosemite’s strategy of building new companies, trust in our extensive grantee and institutional network, and value in our combined experience in shepherding new transformational cancer treatments.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
